Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
JANX · NASDAQ · Pharmaceutical Preparations
$10.08−0.21 (−2.04%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Janux Therapeutics (JANX) · oqro.io/stocks/JANX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Deep Track Capital, LP no longer reported JANX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbimed Advisors LLC disclosed a reduced position in JANX for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deep Track Capital, LP disclosed an increased position in JANX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Orbimed Advisors LLC disclosed a reduced position in JANX for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Paradigm Biocapital Advisors LP no longer reported JANX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Orbimed Advisors LLC disclosed an increased position in JANX for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Orbimed Advisors LLC disclosed an increased position in JANX for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Paradigm Biocapital Advisors LP disclosed a reduced position in JANX for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Perceptive Advisors LLC disclosed a reduced position in JANX for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Orbimed Advisors LLC disclosed an increased position in JANX for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed Aug 6, 2025
Perceptive Advisors LLC disclosed an increased position in JANX for Q1 2025Fund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 23, 2025
Siren, L.L.C. no longer reported JANX for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Ra Capital Management, L.P. disclosed an increased position in JANX for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Paradigm Biocapital Advisors LP disclosed a reduced position in JANX for Q1 2025SourceInsider trade · Traded May 1, 2025 · Filed May 3, 2025
Officer sold ~$94K of JANX shares in the open marketSourceInsider trade · Traded Apr 21, 2025 · Filed Apr 24, 2025
Officer sold ~$100K of JANX shares in the open marketSourceInsider trade · Traded Mar 6, 2025 · Filed Mar 7, 2025
Director purchased ~$11.5M of JANX shares in the open marketSourceInsider trade · Traded Mar 5, 2025 · Filed Mar 7, 2025
Director purchased ~$9.3M of JANX shares in the open marketSourceInsider trade · Traded Mar 7, 2025 · Filed Mar 7, 2025
Director purchased ~$3.42M of JANX shares in the open marketSourceInsider trade · Traded Mar 5, 2025 · Filed Mar 7, 2025
Director purchased ~$1.17M of JANX shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Paradigm Biocapital Advisors LP disclosed an increased position in JANX for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Ra Capital Management, L.P. disclosed an increased position in JANX for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Perceptive Advisors LLC disclosed a new position in JANX for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Siren, L.L.C. disclosed a new position in JANX for Q4 2024Insider trade · Traded Jan 7, 2025 · Filed Jan 9, 2025
CEO sold ~$300K of JANX shares in the open marketSourceInsider trade · Traded Jan 2, 2025 · Filed Jan 3, 2025
Officer sold ~$314K of JANX shares in the open marketSourceInsider trade · Traded Jan 2, 2025 · Filed Jan 3, 2025
Officer sold ~$192K of JANX shares in the open marketSourceInsider trade · Traded Jan 2, 2025 · Filed Jan 3, 2025
Officer sold ~$157K of JANX shares in the open marketSourceInsider trade · Traded Dec 24, 2024 · Filed Dec 28, 2024
CEO sold ~$1.4M of JANX shares in the open marketSourceInsider trade · Traded Dec 3, 2024 · Filed Dec 4, 2024
CEO sold ~$1M of JANX shares in the open marketSourceInsider trade · Traded Nov 25, 2024 · Filed Nov 28, 2024
CEO sold ~$940K of JANX shares in the open marketSourceInsider trade · Traded Nov 25, 2024 · Filed Nov 28, 2024
CEO sold ~$350K of JANX shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Paradigm Biocapital Advisors LP disclosed an increased position in JANX for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Orbimed Advisors LLC disclosed a reduced position in JANX for Q3 2024SourceInsider trade · Traded Oct 28, 2024 · Filed Oct 30, 2024
CEO sold ~$740K of JANX shares in the open marketSourceInsider trade · Traded Oct 28, 2024 · Filed Oct 30, 2024
CEO sold ~$599K of JANX shares in the open marketSourceInsider trade · Traded Sep 13, 2024 · Filed Oct 24, 2024
10% owner sold ~$178K of JANX shares in the open marketSourceInsider trade · Traded Oct 18, 2024 · Filed Oct 22, 2024
Director purchased ~$53.7M of JANX shares in the open marketSourceInsider trade · Traded May 1, 2025 · Filed May 3, 2025
Officer sold ~$13K of JANX shares in the open marketSourceInsider trade · Traded Mar 3, 2025 · Filed Mar 6, 2025
Officer sold ~$78K of JANX shares in the open marketSourceInsider trade · Traded Mar 3, 2025 · Filed Mar 6, 2025
Officer sold ~$30K of JANX shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Orbimed Advisors LLC disclosed a reduced position in JANX for Q4 2024SourceInsider trade · Traded Feb 3, 2025 · Filed Feb 6, 2025
Officer sold ~$102K of JANX shares in the open marketSourceInsider trade · Traded Feb 3, 2025 · Filed Feb 6, 2025
Officer sold ~$35K of JANX shares in the open marketSourceInsider trade · Traded Feb 3, 2025 · Filed Feb 6, 2025
Officer sold ~$4.4K of JANX shares in the open marketSourceInsider trade · Traded Jan 2, 2025 · Filed Jan 3, 2025
Officer sold ~$57K of JANX shares in the open marketSourceInsider trade · Traded Jan 2, 2025 · Filed Jan 3, 2025
Officer sold ~$11K of JANX shares in the open marketSourceInsider trade · Traded Oct 18, 2024 · Filed Oct 18, 2024
10% owner sold ~$24.8M of JANX shares in the open marketSourceInsider trade · Traded Oct 18, 2024 · Filed Oct 18, 2024
10% owner sold ~$24.2M of JANX shares in the open marketSourceInsider trade · Traded Oct 18, 2024 · Filed Oct 18, 2024
10% owner sold ~$5.28M of JANX shares in the open marketSourceInsider trade · Traded Oct 18, 2024 · Filed Oct 18, 2024
10% owner sold ~$5.17M of JANX shares in the open marketSourceInsider trade · Traded Oct 18, 2024 · Filed Oct 18, 2024
10% owner sold ~$4.7M of JANX shares in the open marketSourceInsider trade · Traded Oct 16, 2024 · Filed Oct 18, 2024
10% owner sold ~$3.05M of JANX shares in the open marketSourceInsider trade · Traded Oct 16, 2024 · Filed Oct 18, 2024
10% owner sold ~$2.99M of JANX shares in the open marketSourceInsider trade · Traded Oct 16, 2024 · Filed Oct 18, 2024
10% owner sold ~$1.52M of JANX shares in the open marketSourceInsider trade · Traded Oct 16, 2024 · Filed Oct 18, 2024
10% owner sold ~$1.49M of JANX shares in the open marketSourceInsider trade · Traded Oct 18, 2024 · Filed Oct 18, 2024
10% owner sold ~$1M of JANX shares in the open marketSourceInsider trade · Traded Oct 18, 2024 · Filed Oct 18, 2024
10% owner sold ~$808K of JANX shares in the open marketSourceInsider trade · Traded Oct 18, 2024 · Filed Oct 18, 2024
10% owner sold ~$791K of JANX shares in the open marketSourceInsider trade · Traded Oct 16, 2024 · Filed Oct 18, 2024
10% owner sold ~$579K of JANX shares in the open marketSourceInsider trade · Traded Oct 16, 2024 · Filed Oct 18, 2024
10% owner sold ~$557K of JANX shares in the open marketSourceInsider trade · Traded Oct 16, 2024 · Filed Oct 18, 2024
10% owner sold ~$289K of JANX shares in the open marketSourceInsider trade · Traded Oct 18, 2024 · Filed Oct 18, 2024
10% owner sold ~$153K of JANX shares in the open marketSourceInsider trade · Traded Oct 17, 2024 · Filed Oct 18, 2024
10% owner sold ~$92K of JANX shares in the open marketSource